Skip to main content
All lobbying filings

BGR GOVERNMENT AFFAIRS

BGR GOVERNMENT AFFAIRS filed a Q3 report for REGENERON PHARMACEUTICALS, INC. on October 20, 2026, reporting $90,000 in lobbying income.

Lobbying for REGENERON PHARMACEUTICALS, INC. · Pharmaceutical company

All filings by BGR GOVERNMENT AFFAIRS · Everything REGENERON PHARMACEUTICALS, INC. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$90,000
What the client paid this registrant for the period.
Client based in
New York

Official filing document

 Lobbyists on this filing 5
  • BRENT ALAN DEL MONTE
    Previously held: Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee
  • RAGHAV AGGARWAL
    Previously held: Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior
  • REMY LEIGH BRIM MASON
    Previously held: Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz
  • DANIEL FARMER
    Previously held: Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space
  • JOHN STONE
    Previously held: Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Provide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem